Cash-Strapped Lotus Pharma Explains Capex Decisions
Lotus Pharma Reports Solid 2008 but Still Lacks CashChinaBio Today • Apr. 17, 2009
Lotus Announces Plans for New Manufacturing FacilityChinaBio Today • Jul. 29, 2008
There are no Transcripts on LTUS.
There are no News articles on LTUS.
We currently have no Breaking News on this stock.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
LTUS vs. ETF Alternatives
Lotus Pharmaceuticals is both a licensed manufacturer and distributor of pharmaceutical products in the People's Republic of China. Its principal manufactured products are prescription medicines, including Valsartan, used to reduce hypertension and high blood pressure; Brimonidine Tartrate, a... More
Other News & PR